function create_iframe(htmlfile) { var player = document.getElementById("player"); var existingiframe = document.getElementById("video"); var iframe = document.createElement("iframe"); iframe.setAttribute("src", htmlfile); iframe.setAttribute("title", "video"); iframe.setAttribute("id", "video"); iframe.setAttribute("width", "240"); iframe.setAttribute("height", "230"); iframe.setAttribute("marginwidth", "0"); iframe.setAttribute("marginheight", "0"); iframe.setAttribute("frameborder", "0"); iframe.setAttribute("border", "0"); iframe.setAttribute("scrolling", "no"); iframe.frameBorder = 0; //iframe.innerHTML = "Sorry, you need iframes to view this video. Upgrade to the latest version of your browser."; /* newembed = ''; */ //document.getElementById("player").innerHTML = iframe; player.appendChild(iframe); } function change_video(htmlfile) { var iframe = document.getElementById("video"); iframe.setAttribute("src", htmlfile); }
Welcome from Drs Gabriel Steg and Deepak Bhatt,
Co-Chairs of the REACH Registry.


Steg

Dr Joachim Röther discusses the the two-year analysis

Explore the intriguing recent data with Dr Röther, on the management and outcomes of patients with, or at high risk of, atherothrombosis.



pdf Röther J et al. Two-year cardiovascular event rates of the cerebrovascular disease subpopulation within the REACH Registry Presented by Joachim Röther at the 2008 European Stroke Congress (Nice, France). [PDF - 94 KB]


Access interviews from Drs Bhatt, Steg, Ohman and Alberts to get their perspectives on the registry.





Steg

The importance of the REACH registry

Dr Gabriel Steg, Co-chair with Dr Deepak Bhatt of the REACH registry, outlines the essential information you need to know about this landmark registry of over 68 000 patients with atherothrombosis.



Bhatt

The REACH Registry: Results and implications

Dr Deepak Bhatt brings you up to date on the published and upcoming research from the Registry that will affect your practice.




PieChart

One-year data results

High rates of MI or stroke were found in REACH Registry patients, especially in those with atherothrombosis in multiple beds, whether or not they were symptomatic. This suggests that "atherothrombosis should be addressed as a global arterial disease," note Dr Ph Gabriel Steg and colleagues.

View the abstract to the paper, published in JAMA, and download the comprehensive slide kit (members only).



The REACH registry is a worldwide health survey and one of the biggest international epidemiological registries to date. Over 68 000 people worldwide are now participating, representing the entire spectrum of those at risk.

One-year follow-up data results have been published, and the overall retention rate after two years of follow-up has been very successful.




sponsored by
sanofi aventis BMS
text
 
Upcoming events!
15 August 2008: Local proposal submission deadline
3 September 2008: International Coordinating Committee meeting
NEW! Publications section
Interested in results from REACH Registry studies? Visit the Publications section for a complete listing of global and local articles.
NEW! Investigators Update
Don't miss the latest issue of the REACH registry bulletin Investigators Update, formerly known as The Observer.
Webcast
View the video proceedings of the Regional Investigator Meeting, held on 15 March in Chicago, IL, with special guest Dr Mark Alberts.